Estimated read time: 6–7 minutes
When a client tells you they microdose, the first question most therapists ask themselves isn’t clinical. It’s “Am I allowed to talk about this?”
The short answer is yes. Talking with clients about substances they’re already using is squarely inside a licensed therapist’s role. Where clinicians get into trouble isn’t the conversation. It’s drifting, often with good intentions, into territory that looks like recommending, sourcing, dosing or supervising use.
This guide to microdosing ethics for therapists is about that line: what your scope covers, what the major ethics codes ask of you, and how the legal landscape shapes your risk wherever you practice. If you want help with the conversation itself, start with Your Client Just Told You They Microdose. Now What?. This post is the companion piece on protecting your license while maintaining a supportive and therapeutic relationship with your client/s.
I’m a licensed clinical social worker, not an attorney. Nothing here is legal advice. Laws and board rules change, so check your own state’s regulations and consult a lawyer or your liability carrier when you’re unsure.
The legal landscape in one minute
Many psychedelics, psilocybin included, are Schedule I substances under federal law; even as states move in different directions:
- Regulated programs: A small number of states have created legal, regulated psilocybin services, with licensed centers and trained facilitators. Each program has its own rules about who can provide services and where.
- Decriminalization: Some states and a growing list of cities have decriminalized personal possession or made it a low enforcement priority. Decriminalization is not legal access, and it doesn’t authorize anyone to provide or supervise use.
- Everywhere else: Possession remains illegal under state law.
For therapists and other licensed providers, the practical takeaway is the same almost everywhere. Your license comes from your state board, and your board’s expectations matter more than what’s legal for the public. Even in states with regulated programs, a mental health license alone usually doesn’t authorize you to provide psilocybin services. That typically requires a separate license or registration.
The good news is – providing psilocybin services as described above, is not the same as talking with a client about their microdosing and utilizing a harm reduction approach – which can very well be within your scope.
What’s inside your scope
In nearly every state, a licensed clinician can:
- Assess and ask. Screen for a client’s use of psychedelics and microdosing, the same way you would for alcohol or cannabis.
- Educate on risks. Share accurate, balanced information about known risks, interactions and contraindications, especially with SSRIs, lithium, a personal or family history of psychosis or bipolar disorder, and heart conditions. Use factual sources and resources. If you haven’t completed training to learn about these contraindications, referring and/or consulting with a specialist is recommended.
- Practice harm reduction. Help a client who has already decided to microdose think through safety, set intentions, notice effects and recognize when to stop.
- Support integration. Help clients make meaning of their experiences and bring insights into daily life, just as you would with any other client experience.
- Coordinate care. Encourage clients to communicate with their prescriber (or other providers as relevant), and coordinate with medical providers when there are medication or health concerns.
Where your scope ends
These are the lines most likely to create licensing questions or legal risk:
- Sourcing. Never provide, sell or recommend where to obtain psilocybin or other controlled substances, including “trusted” vendors, growers or friends.
- Dosing. Don’t prescribe or recommend specific doses or protocols unless you’re legally authorized to. Talking about what the research has studied is education; telling a client what to take is not.
- Being present for use. Don’t supervise, attend or “sit with” a client during use outside a legal, licensed or authorized program. This includes telehealth sessions during dosing.
- Referrals to underground providers. Avoid referring clients to unlicensed guides or unvetted practitioners. Ongoing, coordinated work is riskier than a single conversation about options.
What the ethics codes ask of you
Whether you’re an LCSW, LPC, MFT or psychologist, your code of ethics already covers most of this. A few principles do most of the work:
- Competence. Only practice in areas where you have training. Psychedelic-informed care is a specialty. Get education, supervision or consultation before you market it.
- Client self-determination. Respect your client’s right to make their own choices, while making sure those choices are informed.
- Avoiding harm. Screen for contraindications, watch for destabilization and know when to refer to a higher level of care.
- Honesty in advertising. Describe your services accurately. Avoid language that suggests you provide or guide psychedelic use if you don’t.
Informed consent and documentation
A little paperwork goes a long way toward protecting both you and your client:
- Add a psychedelic-informed section to your consent. State clearly that you offer education, harm reduction and integration support, and that you don’t provide, source or supervise the use of controlled substances.
- Document clinically, not legally. Record what’s relevant to treatment: what the client reports, risks you discussed, your clinical reasoning and any referrals or coordination of care. Avoid notes that read like a usage diary.
- Keep your language consistent. Your website, intake forms and notes should all describe the same scope.
- Check confidentiality rules. Discussing a client’s psychedelic use is confidential like any other treatment information. Know your state’s mandated reporting rules and any added protections for substance use records.
Protect your practice
- Call your liability carrier. Ask whether psychedelic integration and harm reduction are covered, and get the answer in writing.
- Build a consultation network. Find peers or a supervisor experienced in psychedelic-informed care for tough questions and cases.
- Get trained. Structured training gives you language, frameworks and screening tools, and it shows your board you take competence and scope of practice seriously.
Where to go from here
Your clients are going to keep microdosing whether or not they tell you. The more confident you are about your scope, the easier it is to stay curious, keep them talking to you and keep your license safe.
If you want to go deeper, the Clinical Microdosing Integration Training is a 16-week certification for licensed therapists. It covers clinical screening, psychopharmacology, ethics and documentation, plus your own 90-day protocol. Not ready for the full training? Download the free guide, Supporting a Client Who Microdoses, a quick clinical reference on contraindications, medication interactions, prescriber referrals and documentation.
Sources
- Pilecki, B., Luoma, J. B., Bathje, G. J., Rhea, J., & Narloch, V. F. (2021). Ethical and legal issues in psychedelic harm reduction and integration therapy. Harm Reduction Journal, 18, 40.
- Mind Medicine Law, Psychedelic legal status map of the United States (reviewed June 2026).
